Title: Marc Parmentier: Innovator in G-Protein Coupled Receptor Research
Introduction
Marc Parmentier is a notable inventor based in Belgium. He has made significant contributions to the field of G-protein coupled receptors, focusing on their roles in various biological processes. Despite having no patents attributed to him, his research has led to important advancements in understanding receptor activity and its implications for health.
Latest Patents
Marc Parmentier's latest patents include two significant inventions. The first is titled "Ligand For G-Protein Coupled Receptor Fprl2 And Uses Thereof." This invention relates to methods, reagents, and kits for detecting formyl peptide receptor like-2 (FPRL2) polypeptide activity in a sample. It also identifies agents that modulate polypeptide activity and includes antibodies raised against FPRL2. Furthermore, it addresses substances for preventing, treating, and alleviating diseases characterized by dysregulation of FPRL2 polypeptide signaling. The second patent is "Ligand For G-Protein Coupled Receptor Gpr43 And Uses Thereof." This invention identifies short-chain fatty acids as natural ligands of the G-protein coupled orphan receptor GPR43. It also relates to assays for identifying agents that modulate GPR43 ligand binding and signaling activity, as well as diagnostic methods and kits that utilize the interaction of GPR43 with short-chain fatty acids.
Career Highlights
Throughout his career, Marc Parmentier has worked with various companies, including Epics Therapeutics and Euroscreen S.A. His work has focused on the intersection of receptor biology and therapeutic applications, contributing to advancements in medical research.
Collaborations
Marc has collaborated with notable individuals in his field, including Emmanuel Le Poul and Michel Detheux. These collaborations have further enriched his research and contributed to the development of innovative solutions in receptor biology.
Conclusion
Marc Parmentier is a dedicated inventor whose work in G-protein coupled receptors has the potential to impact therapeutic strategies for various diseases. His research continues to pave the way for future innovations in the field.